Combination tofacitinib and oral minoxidil treatment for severe alopecia areata - 15/07/21
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Funding sources: Dr King received funding support from The Ranjini and Ajay Poddar Resource Fund for Dermatologic Diseases Research. |
|
Conflicts of interest: Drs Wambier and King are investigators for Concert Pharmaceuticals Inc, Eli Lilly and Company, and Pfizer Inc. Dr Craiglow is a consultant to and has served on advisory boards for Pfizer. Drs Craiglow and King are on speakers bureaus for Pfizer Inc, Regeneron, and Sanofi Genzyme. Dr King is a consultant to and/or has served on advisory boards for Concert Pharmaceuticals Inc, Dermavant Sciences, Eli Lilly and Company, and Pfizer Inc. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?